Why Spark Therapeutics stock price dropped by 40% this morning
December 11, 2017 at 11:06 AM EST
The Philadelphia company is in a hemophilia gene therapy race with a California biotech rival.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|